Acutus Medical, Inc. (NASDAQ: AFIB) reported Q3 EPS of ($0.70), $0.09 better than the analyst estimate of ($0.79). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.63 million.

For earnings history and earnings-related data on Acutus Medical, Inc. (AFIB) click here.